MedTrace Logo

The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder

NCT02657980 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2017-01-26

No results posted yet for this study

Summary

Study Type: Interventional Study Design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment

Conditions

Interventions

DEVICE

Yband(YDT-201N)

transcranial Direct Current Stimulation (tDCS) 2mA for 30 min; 30 sec of ramp-up and -down; left (anode) and right (cathode) Dorsolateral prefrontal cortex (DLPFC)

DEVICE

Sham-Yband(YDT-201N)

transcranial Direct Current Stimulation (tDCS) 2mA for 30 sec; left (anode) and right (cathode) Dorsolateral prefrontal cortex (DLPFC)

Sponsors & Collaborators

  • Severance Hospital

    collaborator OTHER

  • Gangnam Severance Hospital

    collaborator OTHER

  • Myongji Hospital

    collaborator OTHER

  • CHA University

    collaborator OTHER

  • National Health Insurance Service Ilsan Hospital

    collaborator OTHER

  • Ajou University

    collaborator OTHER

  • Hallym University Medical Center

    collaborator OTHER

  • Ybrain Inc.

    lead INDUSTRY

Principal Investigators

  • Seungwoo Lee · Ybrain Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657980 on ClinicalTrials.gov